LPL Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $129K | Buy |
|
|||||
|
2025
Q2 | $151K | Buy |
|
|||||
|
2025
Q1 | $111K | Buy |
|
|||||
|
2024
Q4 | $105K | Sell |
|
|||||
|
2024
Q3 | $121K | Sell |
|
|||||
|
2024
Q2 | $109K | Buy |
|
|||||
|
2024
Q1 | $83.4K | Sell |
|
|||||
|
2023
Q4 | $104K | Sell |
|
|||||
|
2023
Q3 | $132K | Sell |
|
|||||
|
2023
Q2 | $202K | Buy |
|
|||||
|
2023
Q1 | $228K | Buy |
|
|||||
|
2022
Q4 | $279K | Buy |
|
|||||
|
2022
Q3 | $278K | Buy |
|
|||||
|
2022
Q2 | $225K | Sell |
|
|||||
|
2022
Q1 | $444K | Buy |
|
|||||
|
2021
Q4 | $344K | Sell |
|
|||||
|
2021
Q3 | $912K | Sell |
|
|||||
|
2021
Q2 | $1.24M | Buy |
|
|||||
|
2021
Q1 | $430K | Buy |
|
|||||
|
2020
Q4 | $144K | Sell |
|
|||||
|
2020
Q3 | $67K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $124K | Sell |
|
|||||
|
2019
Q1 | $283K | Buy |
|
|||||
|
2018
Q4 | $267K | Sell |
|
|||||
|
2018
Q3 | $266K | Sell |
|
|||||
|
2018
Q2 | $206K | Buy |
|
|||||
|
2018
Q1 | $157K | Sell |
|
|||||
|
2017
Q4 | $170K | Buy |
|